Trying to pin down a trigger for your redness can be exhausting: It could be stress, extreme temperatures, spicy foods, fragrance, alcohol in skin care and in drinks (especially wine), and even ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

The clearance broadens use of Omvoh, which is part of a slate of new medicines Lilly is counting on to build on its success in diabetes and obesity. In its approval announcement Wednesday, Lilly said ...

reflecting Lilly’s ongoing commitment to elevate care and improve outcomes for patients.” The company has submitted marketing applications for the therapy in the stated indication to the European ...

The FDA has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderate to severe active Crohn's disease in adults according to a recent news release. This is its second indication. In ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year Among those who achieved clinical ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity-drug maker tumbled after it slashed its projection for fourth-quarter revenue as the market for drugs that ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight ... Trump administration. Eli Lilly said Monday it would acquire ...